BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31880802)

  • 1. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
    JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Beta-Blocker-Edema-Loop Diuretic Prescribing Cascade: A Prescription Sequence Symmetry Analysis.
    Vouri SM; Morris EJ; Jiang X; Hofer AK; Schmidt S; Pepine C; Winterstein AG; Smith SM
    Am J Hypertens; 2022 Jul; 35(7):601-609. PubMed ID: 35106529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
    Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
    JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade.
    Vouri SM; Morris EJ; Usmani SA; Reise R; Jiang X; Pepine CJ; Manini TM; Malone DC; Winterstein AG
    Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):72-81. PubMed ID: 34553438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.
    Vouri SM; van Tuyl JS; Olsen MA; Xian H; Schootman M
    J Am Pharm Assoc (2003); 2018; 58(5):534-539.e4. PubMed ID: 30033126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Health-Related Quality of Life Among Adults with a Potential Dihydropyridine Calcium Channel Blocker-Loop Diuretic Prescribing Cascade.
    Morris EJ; Brown JD; Manini TM; Vouri SM
    Drugs Aging; 2021 Jul; 38(7):625-632. PubMed ID: 34095980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Provider and Pharmacy Discordance in Potential Calcium Channel Blocker-Loop Diuretic Prescribing Cascade.
    Ndai AM; Morris EJ; Winterstein AG; Vouri SM
    Drugs Aging; 2024 Feb; 41(2):177-186. PubMed ID: 38252391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.
    Weir MR; Rosenberger C; Fink JC
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):963-8. PubMed ID: 11587165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of negative controls in a prescription sequence symmetry analysis to reduce time-varying bias.
    Vouri SM; Jiang X; Morris EJ; Brumback BA; Winterstein AG
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1192-1199. PubMed ID: 33993606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.
    Sequeira RP; Jassim KA; Damanhori AH; Mathur VS
    J Eval Clin Pract; 2002 Nov; 8(4):407-14. PubMed ID: 12421390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
    Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
    Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hiroi S; Shimasaki Y; Kikuchi T; Otsuka Y; Iwasaki K; Ohishi M
    Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
    de la Sierra A
    J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
    Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between gabapentinoids and oedema treated with loop diuretics: A pooled sequence symmetry analysis from the USA and Denmark.
    Vouri SM; Morris EJ; Wang GH; Hashim Jaber Bilal A; Hallas J; Henriksen DP
    Br J Clin Pharmacol; 2022 Dec; 88(12):5269-5294. PubMed ID: 35748326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.